New Patented Medicines Reported to PMPRB

Up to date as of February 14, 2017

Search by:

to

* Note: Drugs with Price Review Records linked from the brand name are only available from 2010 onward (records for 2011 will be populated over the next few months). Summary Reports are available for drug products reported prior to 2010.


YearCompanyBrand NameChemical NameDINTherapeutic UseDate of First SaleStatus
2015AbbvieHolkira Pak 12.5/75/50/250ombitasvir/paritaprevir/ritonavir and dasabuvir02436027Hepatitis C12 Jan 2015Within Guidelines
2015AbbvieTechnivie 12.5/75/50 - 137.5 mg/patchombitasvir/paritaprevir/ritonavir02447711Hepatitis C20 Nov 2015Within Guidelines
2015Actavis Specialty Pharmaceuticals Co.Teflaro - 400 mg/vialceftaroline fosamilAnti-infective9 Apr 2015Within Guidelines
2015Actavis Specialty Pharmaceuticals Co.Fetzima - 20 mg/capsulelevomilnacipran02440970Antidepressant19 Nov 2015Within Guidelines
2015Actavis Specialty Pharmaceuticals Co.Fetzima - 40 mg/capsulelevomilnacipran02440989Antidepressant19 Nov 2015Within Guidelines
2015Alcon Canada Inc.Simbrinzabrinzolamide02435411Glaucoma17 Feb 2015Within Guidelines
2015Allergan Inc.Ella - 30 mg/tabletulipristal acetate02436329Contraceptive1 Sep 2015Within Guidelines
2015Amgen Canada Inc.Repatha - 140 mg/syringeevolocumab02446057Cholesterol28 Sep 2015Subject to Investigation
2015Aspri Pharma Canada Inc.Pantoprazole Magnesium - 40 mg/tabletpantoprazole magnesium02441853Gastroesophageal Disease25 Nov 2015Within Guidelines
2015Astellas Pharma Canada Inc.Xtandi - 40 mg/capsuleenzalutamide02407329Cancer14 Jun 2013 (Patented 24 Mar 2015)Does Not Trigger Investigation
2015AstraZeneca Canada Inc.Forxiga - 5 mg/tabletdapafliflozin propanediol monohydrate02435462Diabetes16 Jan 2015Does Not Trigger Investigation
2015AstraZeneca Canada Inc.Forxiga - 10 mg/tabletdapafliflozin propanediol monohydrate02435470Diabetes16 Jan 2015Within Guidelines
2015AstraZeneca Canada Inc.Movantik - 12.5 mg/tabletnaloxegol oxalate02442167Constipation27 Aug 2015Within Guidelines
2015AstraZeneca Canada Inc.Movantik - 25 mg/tabletnaloxegol oxalate02442175Constipation27 Aug 2015Within Guidelines
2015AstraZeneca Canada Inc.Duaklir Genuair - 412 mcg/doseaclidinium bromide/formoterol fumarate dihydrate inhalation powder02439530Chronic obstructive pulmonary disease (COPD)29 Jun 2015Within Guidelines
2015Bayer Inc.Kogenate FSantihemophilic factor (recombinant)02291533Treatment of Hemophilia A26 Aug 2015Within Guidelines
2015Bayer Inc.Kogenate FSantihemophilic factor (recombinant)02291525Treatment of Hemophilia A12 Aug 2015Within Guidelines
2015Bayer Inc.Kogenate FSantihemophilic factor (recombinant)02302217Treatment of Hemophilia A12 Aug 2015Within Guidelines
2015Bayer Inc.Kogenate FSantihemophilic factor (recombinant)02291517Treatment of Hemophilia A14 Oct 2015Within Guidelines
2015Bayer Inc.Xarelto - 35 mg/kitrivaroxaban02441535Anticoagulant2 Nov 2015Within Guidelines
2015Bayer Inc.Kogenate FSantihemophilic factor (recombinant)02342731Treatment of Hemophilia A8 Jul 2015Within Guidelines
2015Biogen Idec Canada Inc.Plegridy - 125 mcg/syringepeginterferon beta-1a02444399Multiple sclerosis17 Nov 2015Within Guidelines
2015Biogen Idec Canada Inc.Plegridypeginterferon beta-1a02444402Multiple sclerosis17 Nov 2015Subject to Investigation
2015BioSyent Pharma Inc.Cysview - 100 mg/vialhexaminolevulinate hydrochloride02436639Cancer26 Nov 2015Subject to Investigation
2015Boehringer Ingelheim (Canada) Ltd.Jardiance - 10 mg/tabletempagliflozin02443937Diabetes11 Aug 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Jardiance - 25 mg/tabletempagliflozin02443945Diabetes11 Aug 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Ofev - 100 mg/capsulenintedanib02443066Idiopathic Pumonary Fibrosis29 Jun 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Ofev - 150 mg/capsulenintedanib02443074Idiopathic Pumonary Fibrosis29 Jun 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Inspiolto Respimat 2.5/2.5 - 5 mcg/dosetiotropium/olodaterol02441888Chronic obstructive pulmonary disease29 May 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Combivent Respimat 20/100 - 120 mcg/doseipratropium bromide/salbutamol02419106Bronchodilator5 Jan 2015Within Guidelines
2015Boehringer Ingelheim (Canada) Ltd.Spiriva Respimat - 2.5 mcg/actuationtiotropium02435381Bronchodilator18 Dec 2014VCU
2015Bristol-Myers Squibb Canada Co.Daklinza - 30 mg/tabletdaclatasvir02444747Hepatitis C8 Sep 2015Within Guidelines
2015Bristol-Myers Squibb Canada Co.Daklinza - 60 mg/tabletdaclatasvir02444755Hepatitis C8 Sep 2015Within Guidelines
2015Celgene Inc.Revlimid - 20 mg/capsulelenalidomide02440601Anemia28 Sep 2015Within Guidelines
2015Eli Lilly Canada Inc.Cyramza - 10 mg/mLramucirumab02443805Cancer10 Sep 2015Subject to Investigation
2015Eli Lilly Canada Inc.Humalog Kwikpen - 200 unit/mLinsulin lispro02439611Diabetes14 Sep 2015Within Guidelines
2015Eli Lilly Canada Inc.Trulicity - 1.5 mg/mLdulaglutide02448602Diabetes24 Nov 2015Within Guidelines
2015EMD Serono Canada Inc.Pergoveris - 150 unit/kitfollitropin alfa/lutropin alfa02445301Hormone Therapy22 Oct 2015Subject to Investigation
2015Galderma Canada Inc.Pliaglis 70/70 - 140 mg/glidocaine/tetracaine02398028Analgesic22 Sep 2015Subject to Investigation
2015Galderma Canada Inc.Rosiver - 10 mg/givermectin02440342Rosacea25 May 2015Within Guidelines
2015Gilead Sciences Inc.Tybost - 150 mg/tabcobicistat02411423HIV10 Apr 2015Does Not Trigger Investigation
2015Gilead Sciences Inc.Vitekta - 85 mg/tabletelvitegravir02411172HIV22 Apr 2015Within Guidelines
2015Gilead Sciences Inc.Vitekta - 150 mg/tabletelvitegravir02411180HIV22 Apr 2015Within Guidelines
2015Gilead Sciences Inc.Zydelig - 100 mg/tabletidelalisib02438798Chronic lymphocytic leukemia22 Apr 2015Within Guidelines
2015Gilead Sciences Inc.Zydelig - 150 mg/tabletidelalisib02438801Chronic lymphocytic leukemia22 Apr 2015Within Guidelines
2015GlaxoSmithKline Inc.Breo Ellipta 200/25fluticasone furoate/vilanterol02444186Chronic obstructive pulmonary disease (COPD)2 Oct 2015Within Guidelines
2015GlaxoSmithKline Inc.Incruse Ellipta - 62.5 mcg/doseumeclidinum bromide02423596Chronic obstructive pulmonary disease27 Apr 2015Within Guidelines
2015GlaxoSmithKline Inc.FluLaval Tetra - 15 unit/doseQuadrivalent influenza vaccine (inactivated, split virion)02420783Inlfuenza Vaccine14 Nov 2015Within Guidelines
2015Janssen Inc.Sylvant - 100 mg/vialsiltuximab02435128Castleman's disease8 Sep 2015Within Guidelines
2015Janssen Inc.Sylvant - 400 mg/vialsiltuximab02435136Castleman's disease8 Sep 2015Within Guidelines
2015Laptician Opthalmics Inc.Mitosol - 0.2 mg/mLmitomycinGlaucoma22 May 2015VCU
2015MEDA Pharmaceuticals Ltd.Dymista 137/50 - 187 mcg/doseazelastine hydrochloride and fluticasone propionate02432889Seasonal allergic rhinitis31 Mar 2015Within Guidelines
2015Merck Canada Inc.Gardasil 9 - 1 N.A./doseHuman Papillomavirus 9-valent Vaccine, Recombinant02437058HPV18 Mar 2015Within Guidelines
2015Merck Canada Inc.Asmanex Twisthaler - 100 mcg/dosemometasone furoate02438690Asthma8 Apr 2015Subject to Investigation
2015Merck Canada Inc.Keytruda - 50 mg/vialpembrolizumab02441152Metastatic melanoma1 Jun 2015Within Guidelines
2015Merck Canada Inc.Janumet XR 50/500 - 550 mg/tabsitagliptin/metformin hydrochloride02416786Diabetes13 Jan 2015Within Guidelines
2015Merck Canada Inc.Janumet XR 100/1000 - 1100 mg/tabsitagliptin/metformin hydrochloride02416808Diabetes13 Jan 2015Within Guidelines
2015Novartis Pharma Canada Inc.Jakavi - 10 mg/tabruxolitinib02434814Myelofibrosis15 Apr 2015Within Guidelines
2015Novartis Pharma Canada Inc.Zykadia - 150 mg/capsuleceritinib02436779Cancer29 Apr 2015Within Guidelines
2015Novartis Pharma Canada Inc.Cosentyx - 150 mg/mLsecukinumab02438070Psoriasis10 Apr 2015Within Guidelines
2015Novartis Pharma Canada Inc.Exelon Patch 15 - 27 mg/patchrivastigmine02432803Alzheimer disease17 Apr 2015Within Guidelines
2015Novartis Pharma Canada Inc.Fluad Pediatric - 22.5 mcg/doseinfluenza vaccine, surface antigen, inactivated02434881Influenza Vaccine5 Nov 2015Subject to Investigation
2015Novartis Pharma Canada Inc.Signifor LAR - 40 mg/vialpasireotide02437260Acromegaly4 Aug 2015Does Not Trigger Investigation
2015Novartis Pharma Canada Inc.Signifor LAR - 60 mg/vialpasireotide02437279Acromegaly4 Aug 2015Does Not Trigger Investigation
2015Novartis Pharmaceuticals Canada Inc.Entresto 24.3/25.7 - 50 mg/tabletsacubitril/valsartan02446928Cardiovascular13 Nov 2015Within Guidelines
2015Novartis Pharmaceuticals Canada Inc.Entresto 48.6/51.4 - 100 mg/tabletsacubitril/valsartan02446936Cardiovascular13 Nov 2015Within Guidelines
2015Novartis Pharmaceuticals Canada Inc.Entresto 97.2/102.8 - 200 mg/tabletsacubitril/valsartan02446944Cardiovascular13 Nov 2015Within Guidelines
2015Novo Nordisk Canada Inc.NiaStase RT - 1 mg/vialeptacog alfa (activated)02417103Blood coagulation27 May 2015Does Not Trigger Investigation
2015Novo Nordisk Canada Inc.NiaStase RT - 2 mg/vialeptacog alfa (activated)02417111Blood coagulation21 May 2015Does Not Trigger Investigation
2015Novo Nordisk Canada Inc.NiaStase RT - 5 mg/vialeptacog alfa (activated)02417138Blood coagulation21 May 2015Does Not Trigger Investigation
2015Novo Nordisk Canada Inc.Saxenda - 6 mg/mL liraglutide02437899Weight management27 May 2015Within Guidelines
2015Otsuka Canada Pharmaceutical Inc.Jinarctolvaptan02437503Kidney Disease1 Jun 2015Does Not Trigger Investigation
2015Otsuka Canada Pharmaceutical Inc.Jinarctolvaptan02437511Kidney Disease1 Jun 2015Does Not Trigger Investigation
2015Otsuka Canada Pharmaceutical Inc.Jinarctolvaptan02437538Kidney Disease1 Jun 2015Does Not Trigger Investigation
2015Paladin Labs Inc.Iclusig 15 mg/tabletponatinib02437333Leukemia31 Aug 2015Within Guidelines
2015PTC Therapeutics International LimitedTranslarna - 250 mg/pouchatalurenDuchenne muscular dystrophy30 Nov 2015Within Guidelines
2015Sanofi-Aventis Canada Inc.Toujeo SoloSTAR - 300 unit/mLinsulin glargine02441829Diabetes15 Jul 2015Within Guidelines
2015Sanofi-Aventis Canada Inc.Fumagilline - 20 mg/capsulefumagillineDiarrhea20 Feb 2015Within Guidelines
2015Shire Canada Inc.Revestive - 5 mg/vialteduglutide02445727Short Bowel Syndrome28 Oct 2015Within Guidelines
2015Shire Canada Inc.Vyvanse - 10 mg/capsulelisdexamfetamine dimesylate02439603ADHD26 Jun 2015Subject to Investigation
2015Takeda Canada Inc.Tachosil 2/5.5/2.1thrombin/fibrinogen/collagen02439042Hemostasis18 Sep 2015Within Guidelines
2015Takeda Canada Inc.Entyvio - 300 mg/vialvedolizumab02436841Ulcerative colitis21 Apr 2015Within Guidelines
2015Theratechnologies Inc.Egrifta - 1 mg/vialtesamorelin02438712HIV23 Jun 2015Within Guidelines
2015Valeant Canada LPLodalis - 3.75 g/dosecolesevelam hydrochloride02432463Cholesterol2 Apr 2015Does Not Trigger Investigation
2015Vertex Pharmaceuticals Canada Inc.Kalydeco - 50 mg/packivacaftor02442612Cystic Fibrosis14 Sep 2015Within Guidelines
2015Vertex Pharmaceuticals Canada Inc.Kalydeco - 75 mg/packivacaftor02442620Cystic Fibrosis14 Sep 2015Within Guidelines